Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Myeloid Specific Antigen Monoclonal Antibody (BM-4)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA135716

Catalog No. 01-672-022


Only null left
Add to Cart

Description

Description

BM-4 recognizes a nuclear antigen expressed in human granulocytes (83%) monocytes (20%) and myeloid precursor cells residing in lymphoid and non-lymphoid tissues. BM-4 is an early marker of myeloid differentiation. It also reacts with a subset of myeloid leukemia cells. BM-4 has no reactivity with any other cell type in human tissues.

This product provides a new panel of monoclonal antibodies which stain early precursor and mature forms of human myeloid cells. This panel of monoclonal antibodies reacts with antigenic determinants present in normal myeloid cells and leukemias of similar derivation.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Myeloid Specific Antigen
Monoclonal
0.1 mg/mL
PBS with 0.02% sodium azide
P41218
MNDA
Nuclei from Pokeweed mitrogen stimulated human peripheral blood lymphocytes.
100 μg
Primary
Human
Antibody
IgG1
Immunohistochemistry (Frozen)
BM-4
Unconjugated
MNDA
Ifi204; interferon activated gene 204; MNDA; Myeloid cell nuclear differentiation antigen; PYHIN3; rHin-3; SB135
Mouse
Purified
RUO
4332
4°C
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.